AI model predicts which breast-cancer drugs work best
TL;DR - An AI model trained on millions of protein measurements predicts how effectively breast-cancer drugs will work in tissue samples from people with triple-negative breast cancer. The approach could help identify more promising treatments for individual patients.
- The model uses large-scale protein-measurement data to gauge drug effectiveness.
- It was applied to patient-derived triple-negative breast-cancer tissue samples.
- The provided summary does not specify the model architecture, prediction accuracy, or clinical-validation results.